Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF- κB) Signaling Pathway.

CONCLUSIONS Dexmedetomidine post-conditioning can alleviate cerebral ischemia-reperfusion injury in rats by inhibiting the HMGB1/TLR4/NF-kappaB signaling pathway. PMID: 31912804 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31912804?dopt=Abstract

Source: Medical Science Monitor - January 10, 2020 Category: Research Tags: Med Sci Monit Source Type: research